It has been established that p53 exerts its tumor-suppressing effects by repressing four genes that encode proangiogenic factors, including VEGF, basic fibroblast growth factor (bFGF) [72], bFGF-binding protein, and cyclooxygenase-2 (COX-2). The gene discussed is TP53; the disease is neoplasm.